(Q37398056)

20 August 2017

1 reference

title

Penumbral selection of patients for trials of acute stroke therapy (English)

1 reference

20 August 2017

0 references

Jean-Claude Baron

0 references

Geoffrey A Donnan

0 references

Henry Ma

1 reference

20 August 2017

Stephen M Davis

series ordinal

1 reference

20 August 2017

publication date

1 March 2009

1 reference

20 August 2017

1 reference

20 August 2017

1 reference

20 August 2017

1 reference

20 August 2017

page(s)

261-269

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970041-9

20 August 2017

1 reference

7 January 2021

Tissue plasminogen activator for acute ischemic stroke

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970041-9

7 January 2021

Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970041-9

7 January 2021

National US Estimates of Recombinant Tissue Plasminogen Activator Use

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970041-9

7 January 2021

TPA use for stroke in the Registry of the Canadian Stroke Network.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970041-9

7 January 2021

Stroke units, tissue plasminogen activator, aspirin and neuroprotection: which stroke intervention could provide the greatest community benefit?

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970041-9

7 January 2021

Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970041-9

7 January 2021

Third International Stroke Trial

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970041-9

7 January 2021

Thresholds in cerebral ischemia - the ischemic penumbra

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970041-9

7 January 2021

Cortical evoked potential and extracellular K+ and H+ at critical levels of brain ischemia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970041-9

7 January 2021

Mapping the ischaemic penumbra with PET: implications for acute stroke treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970041-9

7 January 2021

The fate of hypoxic tissue on18F-fluoromisonidazole positron emission tomography after ischemic stroke

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970041-9

7 January 2021

Penumbral probability thresholds of cortical flumazenil binding and blood flow predicting tissue outcome in patients with cerebral ischaemia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970041-9

7 January 2021

Magnetic resonance imaging of acute stroke

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970041-9

7 January 2021

Prognostic accuracy of cerebral blood flow measurement by perfusion computed tomography, at the time of emergency room admission, in acute stroke patients

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970041-9

7 January 2021

Clinical-diffusion mismatch predicts the putative penumbra with high specificity

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970041-9

7 January 2021

Practice Guidelines for the Use of Imaging in Transient Ischemic Attacks and Acute Stroke

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970041-9

7 January 2021

Multiple acute stroke syndrome: marker of embolic disease?

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970041-9

7 January 2021

Magnetic resonance imaging and computed tomography in emergency assessment of patients with suspected acute stroke: a prospective comparison

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970041-9

7 January 2021

Effect of Intravenous Thrombolysis on MRI Parameters and Functional Outcome in Acute Stroke <6 Hours

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970041-9

7 January 2021

Neuroimaging, the ischaemic penumbra, and selection of patients for acute stroke therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970041-9

7 January 2021

Selection of thrombolytic therapy beyond 3 h using magnetic resonance imaging

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970041-9

7 January 2021

Imaging of acute stroke

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970041-9

7 January 2021

Beyond mismatch: evolving paradigms in imaging the ischemic penumbra with multimodal magnetic resonance imaging.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970041-9

7 January 2021

Thrombolytic reversal of acute human cerebral ischemic injury shown by diffusion/perfusion magnetic resonance imaging

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970041-9

7 January 2021

Recovery of apparent diffusion coefficient after ischemia-induced spreading depression relates to cerebral perfusion gradient

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970041-9

7 January 2021

Predictors of apparent diffusion coefficient normalization in stroke patients

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970041-9

7 January 2021

How affected is oxygen metabolism in DWI lesions?: A combined acute stroke PET-MR study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970041-9

7 January 2021

Enlargement of human cerebral ischemic lesion volumes measured by diffusion-weighted magnetic resonance imaging

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970041-9

7 January 2021

Prediction of stroke outcome with echoplanar perfusion- and diffusion-weighted MRI

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970041-9

7 January 2021

Persistent poststroke hyperglycemia is independently associated with infarct expansion and worse clinical outcome.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970041-9

7 January 2021

Elevated hematocrit is associated with reduced reperfusion and tissue survival in acute stroke.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970041-9

7 January 2021

Conversion of ischemic brain tissue into infarction increases with age.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970041-9

7 January 2021

A pilot study of normobaric oxygen therapy in acute ischemic stroke

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970041-9

7 January 2021

Utility of an ultrafast magnetic resonance imaging protocol in recent and semi-recent strokes

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970041-9

7 January 2021

Comparison of MRI and CT for detection of acute intracerebral hemorrhage

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970041-9

7 January 2021

High resolution measurement of cerebral blood flow using intravascular tracer bolus passages. Part I: Mathematical approach and statistical analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970041-9

7 January 2021

Non-invasive measurement of perfusion: a critical review of arterial spin labelling techniques

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970041-9

7 January 2021

Tracer arrival timing-insensitive technique for estimating flow in MR perfusion-weighted imaging using singular value decomposition with a block-circulant deconvolution matrix

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970041-9

7 January 2021

Magnetic resonance imaging criteria for thrombolysis in acute cerebral infarct.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970041-9

7 January 2021

Diffusion- and perfusion-weighted MRI. The DWI/PWI mismatch region in acute stroke

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970041-9

7 January 2021

Principles of cerebral perfusion imaging by bolus tracking

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970041-9

7 January 2021

Perfusion-Weighted Magnetic Resonance Imaging Thresholds Identifying Core, Irreversibly Infarcted Tissue

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970041-9

7 January 2021

Model-free arterial spin labelling for cerebral blood flow quantification: introduction of regional arterial input functions identified by factor analysis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970041-9

7 January 2021

Measuring the effects of remifentanil on cerebral blood flow and arterial arrival time using 3D GRASE MRI with pulsed arterial spin labelling

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970041-9

7 January 2021

Mapping of the cerebral vascular response to hypoxia and hypercapnia using quantitative perfusion MRI at 3 T

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970041-9

7 January 2021

Comparison of admission perfusion computed tomography and qualitative diffusion- and perfusion-weighted magnetic resonance imaging in acute stroke patients.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970041-9

7 January 2021

Perfusion computed tomography: prediction of final infarct extent and stroke outcome

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970041-9

7 January 2021

Perfusion CT helps decision making for thrombolysis when there is no clear time of onset.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970041-9

7 January 2021

Comparison of CT perfusion and angiography and MRI in selecting stroke patients for acute treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970041-9

7 January 2021

Color-coded perfused blood volume imaging using multidetector CT: initial results of whole-brain perfusion analysis in acute cerebral ischemia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970041-9

7 January 2021

Low rate of contrast-induced Nephropathy after CT perfusion and CT angiography in acute stroke patients

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970041-9

7 January 2021

Enhanced computed tomography or magnetic resonance imaging: a choice between contrast medium-induced nephropathy and nephrogenic systemic fibrosis?

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970041-9

7 January 2021

Effects of alteplase beyond 3 h after stroke in the Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET): a placebo-controlled randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970041-9

7 January 2021

Magnetic resonance imaging profiles predict clinical response to early reperfusion: the diffusion and perfusion imaging evaluation for understanding stroke evolution (DEFUSE) study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970041-9

7 January 2021

The Desmoteplase in Acute Ischemic Stroke Trial (DIAS)

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970041-9

7 January 2021

Dose Escalation of Desmoteplase for Acute Ischemic Stroke (DEDAS): evidence of safety and efficacy 3 to 9 hours after stroke onset

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970041-9

7 January 2021

Intravenous desmoteplase in patients with acute ischaemic stroke selected by MRI perfusion-diffusion weighted imaging or perfusion CT (DIAS-2): a prospective, randomised, double-blind, placebo-controlled study.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970041-9

7 January 2021

Risk for symptomatic intracerebral hemorrhage after thrombolysis assessed by diffusion-weighted magnetic resonance imaging

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970041-9

7 January 2021

Effect of the Glycine Antagonist Gavestinel on cerebral infarcts in acute stroke patients, a randomized placebo-controlled trial: The GAIN MRI Substudy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970041-9

7 January 2021

Cooling for Acute Ischemic Brain Damage (COOL AID): a feasibility trial of endovascular cooling

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970041-9

7 January 2021

Does the mismatch match the penumbra? Magnetic resonance imaging and positron emission tomography in early ischemic stroke

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970041-9

7 January 2021

How reliable is perfusion MR in acute stroke? Validation and determination of the penumbra threshold against quantitative PET.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970041-9

7 January 2021

Estimation of bolus dispersion effects in perfusion MRI using image-based computational fluid dynamics

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970041-9

7 January 2021

Bolus delay and dispersion in perfusion MRI: implications for tissue predictor models in stroke

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970041-9

7 January 2021

Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. Prolyse in Acute Cerebral Thromboembolism.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970041-9

7 January 2021

Absent middle cerebral artery flow predicts the presence and evolution of the ischemic penumbra

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970041-9

7 January 2021

10.1016/S1474-4422(09)70041-9

Identifiers

DOI

1 reference

20 August 2017

1 reference